description | Gmax has built up an in-house antibody development platform which enables the antibody screening, humanization, and engineering, in order to obtain the antibody candidates with excellent drugability and developability. |
keywords |
Gmax Biopharm LLC.,GPCRs,GPCR mAb discovery platform,Monoclonal Antibody Development Platform |
update time | 2019-08-08 13:33:26 |